Literature DB >> 26778275

Staging of hepatocellular carcinoma: BCLC system, what else!

Xavier Adhoute1, Guillaume Penaranda2, Jean Luc Raoul3, Marc Bourlière1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26778275     DOI: 10.1111/liv.13066

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  3 in total

1.  HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.

Authors:  Michael C Wallace; Yi Huang; David B Preen; George Garas; Leon A Adams; Gerry MacQuillan; Jonathan Tibballs; John Ferguson; Shaun Samuelson; Gary P Jeffrey
Journal:  Dig Dis Sci       Date:  2017-05-25       Impact factor: 3.199

Review 2.  Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

Authors:  Xavier Adhoute; Guillaume Penaranda; Jean Luc Raoul; Patrice Le Treut; Emilie Bollon; Jean Hardwigsen; Paul Castellani; Hervé Perrier; Marc Bourlière
Journal:  World J Hepatol       Date:  2016-06-18

3.  Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Tim A Labeur; Sarah Berhane; Julien Edeline; Jean-Frederic Blanc; Dominik Bettinger; Tim Meyer; Jeroen L A Van Vugt; David W G Ten Cate; Robert A De Man; Ferry A L M Eskens; Alessandro Cucchetti; Laura J Bonnett; Otto M Van Delden; Heinz-Josef Klümpen; R Bart Takkenberg; Philip J Johnson
Journal:  Liver Int       Date:  2019-11-18       Impact factor: 5.828

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.